Demecan is a producer of medical cannabis.
Not only Germany, but also many other European countries have recognized the potential benefits of cannabis as medicine. In all countries with medical access to cannabis, patient numbers have risen sharply in recent years. We want to make care possible in any European country that chooses to provide its citizens and patients with modern cannabis therapies.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 19, 2022 | Debt Financing | — | — | — | — | Detail |
Dec 19, 2022 | Series Unknown | €15M | 4 | — | — | Detail |
Apr 15, 2021 | Series Unknown | — | 2 | Futury Capital | — | Detail |
Mar 9, 2021 | Debt Financing | — | 1 | — | — | Detail |
Oct 4, 2019 | Series A | €7M | 1 | btov Partners | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Feb 5, 2014
Apartment List
|
Secondary Market | $6M | Marketplace | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
btov Partners | — | Series Unknown |
Enexis AB | — | Series Unknown |
Futury Capital | — | Series Unknown |
Mittelständische Beteiligungsgesellschaft Sachsen - MBG | — | Series Unknown |
Volksbank Mittweida eG | — | Debt Financing |